Zając-Spychała Olga, Pawlak Mikołaj A, Karmelita-Katulska Katarzyna, Pilarczyk Jakub, Derwich Katarzyna, Wachowiak Jacek
Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, Szpitalna Str. 27/33, 60-572, Poznan, Poland.
Department of Neurology and Cerebrovascular Disorders, Poznan University of Medical Sciences, Poznan, Poland.
Neuroradiology. 2017 Feb;59(2):147-156. doi: 10.1007/s00234-016-1777-8. Epub 2017 Jan 10.
The aim of this study was to assess the long-term side effects of central nervous system prophylaxis (high-dose chemotherapy alone vs chemotherapy and CNS radiotherapy) according to the ALL IC-BFM 2002.
Thirty-tree children aged 6.7-19.9 years have been studied. The control group consisted of 12 children newly diagnosed with acute lymphoblastic leukemia. We assessed subcortical gray matter volume using automatic MRI segmentation and cognitive performance to identify differences between two therapeutic schemes and patients prior to treatment.
Patients treated with chemotherapy and CNS radiotherapy had smaller hippocampi than two other subgroups and lower IQ score than patients treated with chemotherapy alone. Both treated groups, whether with chemotherapy only or in combination with CNS radiotherapy, had significantly lower volumes of caudate nucleus and performed significantly worse on measures of verbal fluency in comparison with patients prior to treatment. There were no differences in the mean volumes of total white matter, total gray matter, thalamus, putamen, and amygdala between the studied groups.
In all children treated according to the ALL IC-BFM 2002 with high-dose chemotherapy, both decreased volume of selected subcortical structures and cognitive impairment was observed, especially in children who received chemotherapy in combination with reduced dose CNS radiotherapy. In all children treated according to the ALL IC-BFM 2002 with high-dose chemotherapy, both decreased volume of selected subcortical structures and cognitive impairment were observed, especially in children who received chemotherapy in combination with CNS radiotherapy.
本研究旨在根据ALL IC-BFM 2002评估中枢神经系统预防(单独高剂量化疗与化疗及中枢神经系统放疗)的长期副作用。
对33名年龄在6.7至19.9岁的儿童进行了研究。对照组由12名新诊断为急性淋巴细胞白血病的儿童组成。我们使用自动MRI分割技术评估皮质下灰质体积,并通过认知表现来确定两种治疗方案与治疗前患者之间的差异。
接受化疗及中枢神经系统放疗的患者海马体比其他两个亚组小,智商得分低于仅接受化疗的患者。与治疗前的患者相比,两个治疗组,无论是仅接受化疗还是联合中枢神经系统放疗,尾状核体积均显著减小,语言流畅性测试表现均显著较差。研究组之间的总白质、总灰质、丘脑、壳核和杏仁核的平均体积没有差异。
在所有根据ALL IC-BFM 2002接受高剂量化疗的儿童中,均观察到特定皮质下结构体积减小和认知障碍,尤其是在接受化疗联合低剂量中枢神经系统放疗的儿童中。在所有根据ALL IC-BFM 2002接受高剂量化疗的儿童中,均观察到特定皮质下结构体积减小和认知障碍,尤其是在接受化疗联合中枢神经系统放疗的儿童中。